<span style="color: #222222;">The Delhi High Court today directed the Centre to provide a partial list of Over The Counter (OTC) drugs to doctors and pharmacists by 12th September. <br />''<br />''A bench of Chief Justice D N Patel and Justice C Hari Shankar issued the direction on a Public Interest Litigation initiated by the court on its own after receiving a letter from a doctor for formulation of a law relating to OTC drugs and preparation of a list of such medication.</span><br />'' <span style="color: #222222;"><br />'' The Central Government Standing Counsel Ajay Digpaul, representing the Health Ministry told the court that a sub-committee constituted by the 52nd Drugs Consultative Committee (DCC) has already examined the issue raised in the PIL and has given a report on several aspects regarding OTC drugs including its definition, basic characteristics, manufacturing, labeling, distribution, sale and pricing. <br />''<br />''He said that the sub-committee's report was being examined by another sub-committee which shall give its final report in three months to the DCC which will forward it to the Drugs Technical Advisory Board (DTAB) for further consideration.</span><br />'' <span style="color: #222222;"><br />'' The PIL was initiated by the court after receiving a letter from Dr K K Aggarwal, a Padma Shree awardee and the National President of Heart Care Foundation of India (HCFI), seeking formulation of a law regarding OTC drugs and preparation of a list of such medicines in India.</span><br />'' <span style="color: #222222;"><br />'' Aggarwal, who has been appointed as amicus curiae to assist the court in the matter, has contended that the list of OTC drugs would help to advance consumer health because it would allow people to treat or manage many health conditions conveniently and successfully. </span><br />